Pharma Marketing Network

AUGUST 9, 2023

Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.

Packaging 52

Packaging Labelling Communication Pharmaceutical Companies 52

Pharma Marketing Network

AUGUST 9, 2023

Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.

Packaging 40

Packaging Labelling Communication Pharmaceutical Companies 40

pharmaphorum

OCTOBER 27, 2022

The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels. However, the involvement of the company should always be stated.

Communication 98

Communication Packaging Documentation Pharmaceutical Companies 98

ISPE

NOVEMBER 2, 2022

iSpeak Blog. Applying what has been learned over the last three years to update pharmaceutical companies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. Strong and transparent communications and trust are tied to this.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98